It is a pharma private limited company based in Bengaluru, Karnataka, India, established in 2018.
2018 | Bengaluru, Karnataka, India | ActiveScyron Remedies Private Limited, a active private limited company, was established on 12 November 2018 in Bengaluru, Karnataka, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74999KA2018PTC118424. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Deepu Thulasi (Managing Director), Suresh Indu (Director), Saly Alexander (Director). Past directors included Abhinraj Rajan, Anoop Mahesan Asari. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Bharathi #677 13Th Cross1Th Sector Hsr L/O, Kar, Bengaluru, Karnataka, 560102.
U74999KA2018PTC118424
118424
12 November 2018
₹1.00 M
₹1.00 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Scyron Remedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deepu Thulasi | Managing Director | 12 Nov 2018 | Current |
| Suresh Indu | Director | 02 Aug 2019 | Current |
| Saly Alexander | Director | 02 Aug 2019 | Current |
| Alvin Jose Pothadiyil | Director | 02 Aug 2019 | Current |
| Usha Kumari | Director | 02 Aug 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Aug 2019 | Past |
| Pramod Abcsdd | Director | 05 Aug 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Scyron Remedies Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 26.92% decrease. The company also saw a substantial fall in profitability, with a 1736.02% decrease in profit. The company's net worth observed a substantial decline by a decrease of 29.79%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Scyron Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Scyron Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Scyron Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scyron Remedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Scyron Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Scyron Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
Suresh Indu was appointed as a Director was appointed as a Director on 02 Aug 2019 & has been associated with this company since 6 years 4 months . was recorded as a recent event.
Saly Alexander was appointed as a Director was appointed as a Director on 02 Aug 2019 & has been associated with this company since 6 years 4 months . was recorded as a recent event.
The activity Alvin Jose Pothadiyil was appointed as a Director was appointed as a Director on 02 Aug 2019 & has been associated with this company since 6 years 4 months . was completed.
Progress on Usha Kumari was appointed as a Director was appointed as a Director on 02 Aug 2019 & has been associated with this company since 6 years 4 months . was documented.
The CIN of Scyron Remedies Private Limited is U74999KA2018PTC118424.
Scyron Remedies Private Limited is headquartered at Bharathi #677 13Th Cross1Th Sector Hsr L/O, Kar, Bengaluru, Karnataka, 560102.
Scyron Remedies Private Limited was incorporated on 12 November 2018.
The current directors of Scyron Remedies Private Limited are
The primary industry of Scyron Remedies Private Limited is Pharma.
Scyron Remedies Private Limited is unlisted.
The authorized capital of Scyron Remedies Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX